Sirolimus-coated Balloon Versus Drug-eluting Stent in Native Coronary Vessels - TRANSFORM II (TRANSFORM II)
Sponsor: Fondazione Ricerca e Innovazione Cardiovascolare ETS
This NA trial investigates Coronary Artery Disease and Coronary Artery Stenosis and is currently ongoing. Fondazione Ricerca e Innovazione Cardiovascolare ETS leads this study, which shows 13 recorded versions since 2021 — indicating substantial longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
13 versions recorded-
Feb 2026 — Present [monthly]
Active Not Recruiting NA
-
Jan 2026 — Feb 2026 [monthly]
Active Not Recruiting NA
-
Nov 2025 — Jan 2026 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Sep 2025 — Nov 2025 [monthly]
Recruiting NA
-
Sep 2024 — Sep 2025 [monthly]
Recruiting NA
▶ Show 8 earlier versions
-
Aug 2024 — Sep 2024 [monthly]
Recruiting NA
-
Jul 2024 — Aug 2024 [monthly]
Recruiting NA
-
Jun 2023 — Jul 2024 [monthly]
Recruiting NA
-
Jul 2022 — Jun 2023 [monthly]
Recruiting NA
-
Feb 2022 — Jul 2022 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Nov 2021 — Feb 2022 [monthly]
Not Yet Recruiting NA
-
Oct 2021 — Nov 2021 [monthly]
Not Yet Recruiting NA
-
Jun 2021 — Oct 2021 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Fondazione Ricerca e Innovazione Cardiovascolare ETS
For direct contact, visit the study record on ClinicalTrials.gov .